Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 39.79
- Piotroski Score 7.00
- Grade Buy
- Symbol (IRMD)
- Company IRadimed Corporation
- Price $53.50
- Changes Percentage (0.51%)
- Change $0.27
- Day Low $52.70
- Day High $53.81
- Year High $57.95
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
- Last Earnings 10/31/2024
- Ex-Dividend for 5/16 Dividend 11/15/2024
- Dividend Payable 11/25/2024
- Today N/A
- Next Earnings (Estimated) 02/06/2025
- Fiscal Year End N/A
- Average Stock Price Target $60.00
- High Stock Price Target $60.00
- Low Stock Price Target $60.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $1.40
- Trailing P/E Ratio 30.36
- Forward P/E Ratio 30.36
- P/E Growth 30.36
- Net Income $17.19 M
Income Statement
Quarterly
Annual
Latest News of IRMD
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
iRadimed Corp (IRMD) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Shifts
The current backlog, led by strong pump and monitor sales, offers good visibility into the fourth quarter. The variance between top-line growth and net income was attributed to changes in sales commis...
By Yahoo! Finance | 3 weeks ago -
Is IRADIMED CORPORATION's (NASDAQ:IRMD) Stock's Recent Performance A Reflection Of Its Financial Health?
IRADIMED's stock has risen by 5.6% in the past three months, prompting a study of its financial indicators. The focus is on Return on Equity (ROE), a key metric that measures how effectively a company...
By Yahoo! Finance | 2 months ago -
What Does IRADIMED CORPORATION's (NASDAQ:IRMD) Share Price Indicate?
IRADIMED Corporation (NASDAQ:IRMD) has shown price fluctuations on NASDAQGM, offering potential opportunities for investors. Analyzing its current value, growth prospects, and risks is essential befor...
By Yahoo! Finance | 4 months ago
